Effect of an oral contraceptive on serum phosphohexose isomerase activity
Gupta, U.; Khuteta, K.P.; Gupta, R.C.
Indian Journal of Physiology and Pharmacology 27(3): 253-254
1983
ISSN/ISBN: 0019-5499 PMID: 6668056 Document Number: 210999
Document emailed within 1 workday
Related Documents
Yakasaka, A. 1974: Phosphohexose isomerase in the serum and cerebrospinal fluid Rinsho Byori. Japanese Journal of Clinical Pathology 22(10 Suppl): 237Yeshowardhana; Singh, V.S. 1985: Significance of serum phosphohexose isomerase, hexokinase and aldolase in carcinoma ovary Indian Journal of Physiology and Pharmacology 29(1): 51-54
Saravanan, C.S.; Balasubramanian, M.K.; Gopalakrishnan, V.; Govindarajulu, P.; Nanjunda Rao, R. 1977: Biochemical studies in breast carcinoma. 1. Serum phosphohexose isomerase, lactate dehydrogenase and its isoenzyme changes Indian Journal of Cancer 14(1): 38-41
Asseo, P.P.; Tracopoulos, G.D. 1988: Phosphohexose isomerase in lung cancer Clinical Chemistry 34(3): 649-650
Kameniv, V.F. 1974: Colorimetric method of determination of phosphohexose isomerase with the aid of anthrone reagent Laboratornoe Delo 12: 745-746
Vietti, D.; Bonardi, L.; Ferraresi, G.; Ferrero, L. 1981: Determination of phosphohexose isomerase (PHI) as a diagnostic aid in the prognosis of malignant neoplasms Minerva Medica 72(17): 1087-1089
Sangwan, R.S.; Singh, R. 1990: Characterization of amyloplastic phosphohexose isomerase from immature wheat (Triticum aestivum L.) endosperm Indian Journal of Biochemistry and Biophysics 27(1): 23-27
Niinaka, Y.; Paku, S.; Haga, A.; Watanabe, H.; Raz, A. 1998: Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells Cancer Research 58(12): 2667-2674
Osman, M.M.; Toppozada, H.K.; Ghanem, M.H.; Guergis, F.K. 1972: The effect of an oral contraceptive on serum lipids Contraception 5(2): 105-118
Arora, S.; Arora, R.C.; Garg, R.K.; Agarwal, N.; Nautiyal, A. 1988: Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins Indian Journal of Physiology and Pharmacology 32(1): 67-71
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144
Hettiarachchy, N.S.; Sri Kantha, S.S.; Corea, S.M. 1983: The effect of oral contraceptive therapy and of pregnancy on serum folate levels of rural Sri Lankan women British Journal of Nutrition 50(3): 495-501
Larsson-Cohn, U. 1966: An appraisal of the clinical effect of three different oral contraceptive agents and their influence on transaminase activity Acta Obstetricia et Gynecologica Scandinavica 45(4): 499-514
Ramsjö, M.; Aklillu, E.; Bohman, L.; Ingelman-Sundberg, M.; Roh, H.-K.; Bertilsson, L. 2010: CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking European Journal of Clinical Pharmacology 66(9): 871-877
Edelman, A.; Munar, M.; Elman, M.R.; Koop, D.; Cherala, G. 2012: Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women British Journal of Clinical Pharmacology 74(3): 510-514
Namli Kalem, M.üb.; Hizli, D.; Kamalak, Z.; Kösüs, A.; Kösüs, N.; Turhan, N.ün.; Kafali, H. 2016: Effect of combined oral contraceptive use on serum 25-hydroxy vitamin D levels and ultrasound parameters in patients with polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 32(4): 281-284
Kalbag, J.; Elder, C.; Scott, G.; Wang, Y.; Milosavljev, S.; Leese, P.; Caldwell, J.; Rordorf, C. 2004: Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profile Journal of Clinical Pharmacology 44(6): 646-654
Sullivan, H.; Furniss, H.; Spona, J.; Elstein, M. 1999: Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity Fertility and Sterility 72(1): 115-120
Minozzi, M.; Costantino, D.; Guaraldi, C.; Unfer, V. 2011: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(11): 920-924
Biswal, S.; Veldandi, U.K.; Derne, C.; Golla, G.; Muhsen, N.; Legangneux, E. 2014: Effect of oral siponimod (BAF312) on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female subjects International Journal of Clinical Pharmacology and Therapeutics 52(11): 996-1004